Hemogenyx Pharmaceuticals Plc (HEMO.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 09:42AM BST. Market open.
| Previous close | 1.5850 |
| Open | 1.6000 |
| Bid | 1.6220 x 0 |
| Ask | 1.6740 x 0 |
| Day's range | 1.6000 - 1.6500 |
| 52-week range | 1.1000 - 7.1340 |
| Volume | |
| Avg. volume | 16,485,278 |
| Market cap | 22.14M |
| Beta (5Y monthly) | 3.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ACCESSWIREHemogenyx Pharmaceuticals PLC Announces CBR Brain Delivery
Chimeric Bait Receptors for Combatting Brain Cancers and Neurodegenerative Diseases Can Be Delivered via Programmed Microglial Cells LONDON, UK / ACCESSWIRE / February 16, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the clinical stage biopharmaceutical ...
Simply Wall St.Is Hemogenyx Pharmaceuticals (LON:HEMO) In A Good Position To Deliver On Growth Plans?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-T
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the Company has received a notice from the U.S.
© 2024 Yahoo. All rights reserved.